Validation studies with the micronucleus test for early spermatids of rats. A tool for detecting clastogenicity of chemicals in differentiating spermatogonia and spermatocytes.
Male Wistar rats were given a single i.p. injection with different doses of ethylnitrosourea, mitomycin C, methyl methanesulphonate, cyclophosphamide or vincristine sulphate. Clastogenic damage induced in differentiating spermatogonia and spermatocytes was measured by counting micronuclei in derived early spermatids. At dose levels not resulting in cell death of resting spermatocytes, all chemicals--with the exception of vincristine--induced most of the damage in G1- and S-phase of primary spermatocytes (also called resting, pre-leptotene or pre-meiotic spermatocytes). However, at doses causing death of G1- and S-phase spermatocytes, high frequencies of micronuclei may be observed in early spermatids derived from spermatocytes treated in diplotene, diakinesis and MI and II. This is exemplified by our results with ethylnitrosourea. In our experience, the most sensitive stage of primary spermatocyte development (i.e. G1- and S-phase cells) can best be sampled 20 days after treatment. This is the optimal time interval for demonstrating the clastogenic potential of low or moderate doses of a test chemical in meiotic male germ cells of rats. The optimal sampling time for the detection of typical spindle poisons remains to be established. In general, at low or moderate dose levels, smaller or negligible amounts of chromosomal damage were induced in differentiating spermatogonia, in spermatocytes in meiotic prophase and in dividing primary or secondary spermatocytes. For obvious reasons, the micronucleus test for early spermatids cannot be used to detect clastogens which act exclusively on postmeiotic male germ cells.
Tates
A D
AD
MGC-Department of Radiation Genetics and Chemical Mutagenesis, State University of Leiden, Sylvius Laboratory, The Netherlands.
D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology; D005038:Ethylnitrosourea / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D008297:Male; D008741:Methyl Methanesulfonate / Q000494:pharmacology; D051379:Mice; D015162:Micronucleus Tests / Q000379:methods*; D016685:Mitomycin / Q000494:pharmacology; D009153:Mutagens / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013087:Spermatids / Q000187:drug effects* / Q000648:ultrastructure; D013090:Spermatocytes / Q000187:drug effects / Q000648:ultrastructure; D013093:Spermatogonia / Q000187:drug effects / Q000648:ultrastructure; D014750:Vincristine / Q000494:pharmacology
D009153:Mutagens; D016685:Mitomycin; D014750:Vincristine; D003520:Cyclophosphamide; D008741:Methyl Methanesulfonate; D005038:Ethylnitrosourea